About

From volume to value

Lens

Monday, October 8th, 2018 - Zurich

Download the brochure

From volume to value

The use of Real Word Evidence to improve clinical programs and patients’ lives

The world of clinical research is in a phase of profound transformation.

The acceleration of scientific knowledge in recent years is leading to an exponential increase in the number of clinical trials with new drugs. This increase in studies is associated with a profound methodological transformation, which leads to overcoming the classical model of development based on the sequentially managed phases for individual New Chemicals Entities and New Biological Entities. Nowadays pharma is undergoing an ‘evidence revolution’ as real-world evidence infiltrates every part of the life of a medicine.
In this setting studies that use Real Word Data (RWD), reflecting actual outcomes within the setting of clinical care, are fundamental tools that helps to paint a detailed picture of a medicine’s impact on the lives of a patient population and to formulate better hypotheses to be tested in clinical research.
Therefore, in order to design and successfully execute a RWD collection, it is essential to handle the principles of epidemiology and outcome research and to have a very good knowledge of observational methods.

This meeting will explore the RWD regulatory framework that is increasingly developing to govern the use of personal data in the health domain, as well the latest methodological approaches and the opportunities around the product lifecycle. In this context the involvement of new technologies became also crucial in a world where the availability of electronic patient-level data and the ability to analyse it is increased.

The eighth edition of the European Epidemiological Forum is therefore dedicated to the use of Real World Evidence (RWE) to improve clinical programs and patients’ lives. This will include presentations focusing on:

  • Regulatory aspects
  • New technologies and their impact on clinical research
  • Pragmatic trials
  • RWE “in practice”
  • Patient Reported Outcomes (PRO) and Patient engagement

This event aims to bring together experts not only from the world of clinical research but also from academia, public institutions and industry to exchange views and experiences among all the participants, providing networking opportunities and discussion between speakers and audience.

Scientific Board:

Giovanni FioriScientific Director at MEDINEOS Observational Research
Anna-Katharina MeineckeRWE Strategy & Outcomes Data Generation at Bayer AG

Who should attend?

The event is addressed to professionals with a deep interest in drug development, healthcare decision making, academia and healthcare research, belonging to department such as:

• R&D
• Medical Affairs
• HTA/ Market access
• Medical Informatics
• Clinical Operations
• Regulatory Affairs
• Pharmacovigilance
• Biostatistics and Data Management

from Pharmaceutical, Biotechnology and Medical Device companies, CROs, Universities/Hospitals, Academic Research, Patient Associations and Healthcare Organizations.

Please click here to read the code of good conduct

Taking part in our events, you support “The Vase of Flowers” project

Vaso di Fiori

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more